Molecular Partners CEO Zahnd resigns

Molecular Partners AG (SIX:MOLN) said CEO Christian Zahnd resigned due to health reasons. Zahnd will remain a member of the board. CBO and COO Patrick Amstutz will be interim CEO as the company searches for Zahnd's replacement.

Last year, Amstutz and Chairman Joern Aldag handled Zahnd's responsibilities during his five-month medical leave (see BioCentury Extra, March 10, 2015)...